Analgesic Effect of an Injection of Botulinum Toxin Type A in the Ganglion Impar in Patients With Chronic Proctalgia
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The main objective is to evaluate the analgesic efficacy of botulinum toxin type A in
refractory chronic proctalgia one month after a bilateral injection of 50 units of Botox ® in
the ganglion Impar (total dose = 100 units)
Phase:
Phase 2
Details
Lead Sponsor:
Nantes University Hospital
Treatments:
abobotulinumtoxinA Analgesics Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA